Implemed, Inc. based out of Massachusetts, reportedly
received govermental approval to market a line of products ( "Oligon"
) in Eastern Europe. The silver-based central venous catheters release silver
ions from the catheter into tissues through the electrolsysis method of
silver ion production. The company claims the process is effective against
antibiotic resistant gram-negative and gram-positive bacteria, as well as